Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQA3526 in Primary Biliary Cholangitis
CTR20200055Phase 2Terminated
- Sponsor
- Jiangsu Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TQA3526 in primary biliary cholangitis (PBC), sponsored by Jiangsu Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.. Started Jan 2020; status: terminated.
02
Drugs
TQA3526
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on CTR20200055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200055.